COVID-19 Saliva Screening Test Potential Market Size, Share, Trends, Growth 2032

COVID-19 Saliva Screening Test Potential Market

COVID-19 Saliva Screening Test Potential Market By Technology (Fluorescence-labelled antigen, RT-PCR, and CRISPR-Cas9), By Mode of Testing (Centralized Testing and Decentralized Testing), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032

Category: Biotechnology Report Format : PDF Pages: 110 Report Code: ZMR-6469 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 351.51 Million USD 702.67 Million 8% 2023

COVID-19 Saliva Screening Test Potential Market

Request For Customization Request Free Sample Buy Now

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. COVID-19 Saliva Screening Test Potential Market, 2018–2028(USD Billion)
    • 2.2. COVID-19 Saliva Screening Test Potential Market: Snapshot
  • Chapter 3. Global COVID-19 Saliva Screening Test Potential Market– End-Use Analysis
    • 3.1. COVID-19 Saliva Screening Test Potential Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Salivary specimen cullection is non-invasive and can minimize exposure of health workers to COVID-19 disease to a large extent, thereby embellishing growth of market.
      • 3.2.2. The saliva cullection can also be used for sequential determination of viral load and this will promulgate market value in the next couple of years.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Technology
      • 3.4.2. Market attractiveness analysis By Mode of Testing
  • Chapter 4. Global COVID-19 Saliva Screening Test Potential Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global COVID-19 Saliva Screening Test Potential Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global COVID-19 Saliva Screening Test Potential Market– Technology Analysis
    • 5.1. Global COVID-19 Saliva Screening Test Potential Market overview: By Technology
      • 5.1.1. Global COVID-19 Saliva Screening Test Potential Market share, By Technology, 2020 and 2028
    • 5.2. Fluorescence-labelled antigen
      • 5.2.1. Global COVID-19 Saliva Screening Test Potential Market by Fluorescence-labelled antigen, 2018–2028(USD Billion)
    • 5.3. RT-PCR
      • 5.3.1. Global COVID-19 Saliva Screening Test Potential Market by RT-PCR, 2018–2028(USD Billion)
    • 5.4. CRISPR-Cas9
      • 5.4.1. Global COVID-19 Saliva Screening Test Potential Market by CRISPR-Cas9, 2018–2028(USD Billion)
  • Chapter 6. Global COVID-19 Saliva Screening Test Potential Market– Mode of Testing Analysis
    • 6.1. Global COVID-19 Saliva Screening Test Potential Market overview: By Mode of Testing
      • 6.1.1. Global COVID-19 Saliva Screening Test Potential Market share, By Mode of Testing, 2020 and 2028
    • 6.2. Centralized Testing
      • 6.2.1. Global COVID-19 Saliva Screening Test Potential Market by Centralized Testing, 2018–2028(USD Billion)
    • 6.3. Decentralized Testing
      • 6.3.1. Global COVID-19 Saliva Screening Test Potential Market by Decentralized Testing, 2018–2028(USD Billion)
  • Chapter 7. Company Profiles
    • 7.1. ARUP Labs
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Product Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Psomagen, Inc.
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Product Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. Vatic Health
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Product Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Development
    • 7.4. MOgene
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Product Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Development
    • 7.5. Fluidigm Corporation
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Product Portfolio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Development
    • 7.6. Phosphorus Diagnostics LLC
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Product Portfolio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Development
    • 7.7. Quidel Corporation
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Product Portfolio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Development
    • 7.8. Abbot Laboratories
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Product Portfolio
      • 7.8.4. Business Strategy
      • 7.8.5. Recent Development
    • 7.9. FLuroTech Ltd.
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Product Portfolio
      • 7.9.4. Business Strategy
      • 7.9.5. Recent Development
    • 7.10. LumiraDX
      • 7.10.1. Overview
      • 7.10.2. Financials
      • 7.10.3. Product Portfolio
      • 7.10.4. Business Strategy
      • 7.10.5. Recent Development
    • 7.11. Gravity Diagnostics
      • 7.11.1. Overview
      • 7.11.2. Financials
      • 7.11.3. Product Portfolio
      • 7.11.4. Business Strategy
      • 7.11.5. Recent Development
    • 7.12. Ambry Genetics
      • 7.12.1. Overview
      • 7.12.2. Financials
      • 7.12.3. Product Portfolio
      • 7.12.4. Business Strategy
      • 7.12.5. Recent Development
    • 7.13. DxTerity Diagnostics, Inc.
      • 7.13.1. Overview
      • 7.13.2. Financials
      • 7.13.3. Product Portfolio
      • 7.13.4. Business Strategy
      • 7.13.5. Recent Development

Table Of Figures

List of Figures

1. Market research Type
2. Market research methodology
3. Global COVID-19 Saliva Screening Test Potential Market, 2018–2028(USD Billion)
4. Porter’s Five Forces Analysis
5. Global COVID-19 Saliva Screening Test Potential Marketattractiveness, By Technology
6. Global COVID-19 Saliva Screening Test Potential Marketattractiveness, By Mode of Testing
7. Global COVID-19 Saliva Screening Test Potential Marketshare by Technology ,2020 and 2028 (USD Billion)
8. Global COVID-19 Saliva Screening Test Potential Marketby Fluorescence-labelled antigen, 2018–2028(USD Billion)
9. Global COVID-19 Saliva Screening Test Potential Marketby RT-PCR, 2018–2028(USD Billion)
10. Global COVID-19 Saliva Screening Test Potential Marketby CRISPR-CaS9, 2018–2028(USD Billion)
11. Global COVID-19 Saliva Screening Test Potential Marketshare by Mode of Testing ,2020 and 2028 (USD Billion)
12. Global COVID-19 Saliva Screening Test Potential Marketby Centralized Testing, 2018–2028(USD Billion)
13. Global COVID-19 Saliva Screening Test Potential Marketby Decentralized Testing, 2018–2028(USD Billion)
14. Global COVID-19 Saliva Screening Test Potential Marketshare, by Region, 2020 and 2028
15. North America COVID-19 Saliva Screening Test Potential Market, 2018–2028(USD Billion)
16. Europe COVID-19 Saliva Screening Test Potential Market, 2018–2028(USD Billion)
17. Asia Pacific COVID-19 Saliva Screening Test Potential Market, 2018–2028(USD Billion)
18. Latin America COVID-19 Saliva Screening Test Potential Market, 2018–2028(USD Billion)
19. The Middle East and Africa COVID-19 Saliva Screening Test Potential Market, 2018–2028(USD Billion)
 


Table Of Tables

List of Tables

1. Global COVID-19 Saliva Screening Test Potential Market: snapshot
2. Drivers of the COVID-19 Saliva Screening Test Potential Market: impact analysis
3. North America COVID-19 Saliva Screening Test Potential Market revenue, By Technology  ,2018–2028(USD Billion)
4. North America COVID-19 Saliva Screening Test Potential Market revenue, By Mode of Testing  ,2018–2028(USD Billion)
5. The U.S. COVID-19 Saliva Screening Test Potential Market revenue, By Technology  ,2018–2028(USD Billion)
6. The U.S. COVID-19 Saliva Screening Test Potential Market revenue, By Mode of Testing  ,2018–2028(USD Billion)
7. Rest of North America COVID-19 Saliva Screening Test Potential Market revenue, By Technology  ,2018–2028(USD Billion)
8. Rest of North America COVID-19 Saliva Screening Test Potential Market revenue, By Mode of Testing  ,2018–2028(USD Billion)
9. Europe COVID-19 Saliva Screening Test Potential Market revenue, By Technology  ,2018–2028(USD Billion)
10. Europe COVID-19 Saliva Screening Test Potential Market revenue, By Mode of Testing  ,2018–2028(USD Billion)
11. UK COVID-19 Saliva Screening Test Potential Market revenue, By Technology  ,2018–2028(USD Billion)
12. UK COVID-19 Saliva Screening Test Potential Market revenue, By Mode of Testing  ,2018–2028(USD Billion)
13. France COVID-19 Saliva Screening Test Potential Market revenue, By Technology  ,2018–2028(USD Billion)
14. France COVID-19 Saliva Screening Test Potential Market revenue, By Mode of Testing  ,2018–2028(USD Billion)
15. Germany COVID-19 Saliva Screening Test Potential Market revenue, By Technology  ,2018–2028(USD Billion)
16. Germany COVID-19 Saliva Screening Test Potential Market revenue, By Mode of Testing  ,2018–2028(USD Billion)
17. Rest of Europe COVID-19 Saliva Screening Test Potential Market revenue, By Technology  ,2018–2028(USD Billion)
18. Rest of Europe COVID-19 Saliva Screening Test Potential Market revenue, By Mode of Testing  ,2018–2028(USD Billion)
19. Asia Pacific COVID-19 Saliva Screening Test Potential Market revenue, By Technology  ,2018–2028(USD Billion)
20. Asia Pacific COVID-19 Saliva Screening Test Potential Market revenue, By Mode of Testing  ,2018–2028(USD Billion)
21. China COVID-19 Saliva Screening Test Potential Market revenue, By Technology  ,2018–2028(USD Billion)
22. China COVID-19 Saliva Screening Test Potential Market revenue, By Mode of Testing  ,2018–2028(USD Billion)
23. Japan COVID-19 Saliva Screening Test Potential Market revenue, By Technology  ,2018–2028(USD Billion)
24. Japan COVID-19 Saliva Screening Test Potential Market revenue, By Mode of Testing  ,2018–2028(USD Billion)
25. India COVID-19 Saliva Screening Test Potential Market revenue, By Technology  ,2018–2028(USD Billion)
26. India COVID-19 Saliva Screening Test Potential Market revenue, By Mode of Testing  ,2018–2028(USD Billion)
27. Rest of Asia Pacific COVID-19 Saliva Screening Test Potential Market revenue, By Technology  ,2018–2028(USD Billion)
28. Rest of Asia Pacific COVID-19 Saliva Screening Test Potential Market revenue, By Mode of Testing  ,2018–2028(USD Billion)
29. Latin America COVID-19 Saliva Screening Test Potential Market revenue, By Technology  ,2018–2028(USD Billion)
30. Latin America COVID-19 Saliva Screening Test Potential Market revenue, By Mode of Testing  ,2018–2028(USD Billion)
31. Brazil COVID-19 Saliva Screening Test Potential Market revenue, By Technology  ,2018–2028(USD Billion)
32. Brazil COVID-19 Saliva Screening Test Potential Market revenue, By Mode of Testing  ,2018–2028(USD Billion)
33. Rest of Latin America COVID-19 Saliva Screening Test Potential Market revenue, By Technology  ,2018–2028(USD Billion)
34. Rest of Latin  America COVID-19 Saliva Screening Test Potential Market revenue, By Mode of Testing  ,2018–2028(USD Billion)
35. The Middle East and Africa COVID-19 Saliva Screening Test Potential Market revenue, By Technology  ,2018–2028(USD Billion)
36. The Middle East and Africa COVID-19 Saliva Screening Test Potential Market revenue, By Mode of Testing  ,2018–2028(USD Billion)
37. Saudi Arabia COVID-19 Saliva Screening Test Potential Market revenue, By Technology  ,2018–2028(USD Billion)
38. Saudi Arabia COVID-19 Saliva Screening Test Potential Market revenue, By Mode of Testing  ,2018–2028(USD Billion)
39. South Africa COVID-19 Saliva Screening Test Potential Market revenue, By Technology  ,2018–2028(USD Billion)
40. South Africa COVID-19 Saliva Screening Test Potential Market revenue, By Mode of Testing  ,2018–2028(USD Billion)
41. Rest of the Middle East & Africa COVID-19 Saliva Screening Test Potential Market revenue, By Technology  ,2018–2028(USD Billion)
42. Rest of the Middle East & Africa COVID-19 Saliva Screening Test Potential Market revenue, By Mode of Testing  ,2018–2028(USD Billion)

 
 

Methodology

FrequentlyAsked Questions

Accurate diagnosing of COVID 19 is key for containing disease in clinics and community set-up and testing of salivary specimens of individuals have proved to be technically advantageous as compared to testing of blood or any other body fluids. This, in turn, will drive growth of COVID-19 saliva screening test potential market over the years ahead. In addition to this, saliva can be easily self-collected by children & adults with patient spitting in sterile container. Hence, collection of saliva eliminates requirement of services of healthcare professionals along with reducing nosocomial infections.

According to a report from Zion Market Research, the global COVID-19 Saliva Screening Test Potential Market was valued at USD 351.51 Million in 2023 and is projected to hit USD 702.67 Million by 2032, with a compound annual growth rate (CAGR) of 8% during the forecast period 2024-2032.

North America will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is due to launching of myriad products by startups. Apart from this, presence of key participants in the sub-continent involved in development of diagnostics & screening tests is likely to contribute majorly towards regional market size over the upcoming years.

 

The key market participants include ARUP Labs, Psomagen, Inc., Vatic Health, MOgene, Fluidigm Corporation, Phosphorus Diagnostics LLC, Quidel Corporation, Abbot Laboratories, FLuroTech Ltd., LumiraDX, Gravity Diagnostics, Ambry Genetics, and DxTerity Diagnostics, Inc.

Choose License Type

  • zion payment modes

List of Contents

Market InsightsOverviewGrowth DynamicsReport ScopeRegional LandscapeCompetitive SpaceThe global Market is segmented as follows:

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed